论文部分内容阅读
AIM: To develop a high performance liquid chromatography-electrospray mass spectrometry (HPLC-MS/ESI) method for simultaneous determination of quetiapine and its sulfoxide-, 7-hydroxy-, 7-hydroxy-N-dealkyl-metabo-lites in human plasma. METHODS: The HPLC separation of the compounds was performed on a Kromasil C18, (5 urn, 4.6 mm×150 mm) column, using water (formic acid: 1.70 mmol/L, ammonium acetate: 5.8 mmol/L)-acetoni trile (65:35) as mobile phase, with a flow-rate of 0.95 mL/min. The compounds were ionized in the electrospray ionization (ESI) ion source of the mass spectrometer and detected in the selected ion recording (SIR) mode. The samples were extracted using solid-phase extraction columns. RESULTS: The calibration curves were linear in the ranges of 10-2000 μg/L for quetiapine, 1-200 μg/L for its metabolites, respectively. The average extraction recoveries for all the four samples were above 85 %.
AIM: To develop a high performance liquid chromatography-electrospray mass spectrometry (HPLC-MS / ESI) method for simultaneous determination of quetiapine and its sulfoxide-, 7-hydroxy-, 7-hydroxy-N-dealkyl-metabo-lites in human plasma . METHODS: The HPLC separation of the compounds was performed on a Kromasil C18, (5 urn, 4.6 mm × 150 mm) column, using water (formic acid: 1.70 mmol / L, ammonium acetate: 5.8 mmol / L) (65:35) as mobile phase, with a flow-rate of 0.95 mL / min. The compounds were ionized in the electrospray ionization (ESI) ion source of the mass spectrometer and detected in the selected ion recording (SIR) mode. samples were extracted using solid-phase extraction columns. respectively: The calibration curves were linear in the ranges of 10-2000 μg / L for quetiapine, 1-200 μg / L for its metabolites, respectively. The average extraction recoveries for all the four samples were above 85%.